Latest News
Educational Areas
- mRCC Tool Danish Version
Webinars & Events
Digital Patient Support
Order Support Materials
Login

Search

Home
Cabozantinib for the treament of Neuroendocrine Tumors

Back to overview

April 17, 2026

1 minute

Cabozantinib for the treament of Neuroendocrine Tumors

Speakers: Eva Tiensuu Janson, Marianne Pavel & Staffan Welin
Date: February 2026

Relevant Content

April 17, 2026

How to Optimize the Treatment in First Line RCC

Webinars & Events
Time: 1 minute

September 5, 2025

Patient cases TKI-biverkningar

Webinars & Events
Time: 1 minute

March 25, 2025

Adjuvant treatment in RCC Updated KEYNOTE-564 OS data Consideration of side effects and subgroups of patients

Webinars & Events
Time: 1 minute

This site is intended for HCPs only. It is produced by Ipsen International team, not intended to specific countries and not intended to US audience. The views expressed by speakers participating in the ON webinars are those of the speakers and not, necessarily, of Ipsen.

Terms & Conditions
Privacy Policy
Cookie Policy
Report Adverse Events

This website is provided by Ipsen: IPSEN AB, Färögatan 33, SE- 164 51 Kista, Sweden. | www.ipsen.com/nordics CBZ-NOR-000201 2024 03.